Category: Vestibular Training

Vestibular Training

Otolith Vertigo Treatment Is FDA ‘Breakthrough Device’

Otolith Labs’ noninvasive vestibular system masking (nVSM) technology is designed to provide acute treatment for vestibulogenic vertigo.

Vestibular Training

Interacoustics Adds TRV Rotational Chair for BPPV Patients

According to the company's announcement, the TRV Chair is designed for “the efficient and accurate diagnosis and treatment of benign paroxysmal positional vertigo (BPPV)—the single most common cause of acute vertigo.”

Vestibular Training

William Demant Foundation Donates $6 Million to Denmark Hearing and Balance Center

In the summer of 2020, the Capital Region of Denmark will consolidate all specialist treatment at a new hearing and balance center at Rigshospitalet to help patients suffering from poor hearing and dizziness.

Dizziness Drug May Improve Long-term Memory, Say University of Tokyo Researchers

by Stefani Kim | Jan 10, 2019 | Vestibular Care, Vestibular Training, Vestibular Treatment | 0

During recent studies by researchers in Japan, histamine improved people’s long-term memory test scores depending on the strength of the original memory and could temporarily extend mice memories by as much as 25 days longer than normal. Clarifying the role of histamine in memory may help alleviate symptoms of memory disorders, such as Alzheimer’s disease and other forms of dementia.

Sensorion Announces Positive Topline Results from Vertigo Drug Study

by Stefani Kim | Dec 17, 2018 | Vestibular Care, Vestibular Training, Vestibular Treatment | 0

The company reports that Seliforant, in contrast to Meclizine, has no negative CNS side effects such as sedation, impairment of memory, and cognitive performance.

NIDCD’s Mission Focuses on Hearing and Balance Research

by Stefani Kim | Dec 11, 2018 | Vestibular Testing, Vestibular Training | 0

According to Judith Cooper, PhD—acting director of the NIDCD and director of the NIDCD Division of Scientific Programs who is quoted in the article—NIDCD research is primarily focused on identifying hearing loss genes; determining barriers to treatment and evaluating new “service delivery and screening models,” and the application of cochlear implant technology in the development of “other neural prostheses.”

Sensorion and Pasteur Institute to Collaborate on Gene Therapy Products

by Karl | Nov 28, 2018 | Vestibular Training, Vestibular Treatment | 0

Sensorion announced a letter of intent with Pasteur Institute in Paris to exclusively negotiate a framework agreement to obtain the exclusive licenses to develop and commercialize gene therapy product candidates for restoration, treatment, and prevention of hearing loss disorders. They will collaborate on several lead programs to correct monogenic forms of hereditary hearing loss including, among others, the Usher syndrome type 1 and otoferlin deficiency, according to the announcement.

DizzyDoctor to Partner with Seamgen on Vertigo Recording Application

by Stefani Kim | Nov 27, 2018 | Vestibular Care, Vestibular Training, Vestibular Treatment | 0

The data, if collected properly, will help allow a physician to better identify why a patient has episodes of dizziness. Recordings from the application—including video, motion, and pupil tracking—are all said to be automatically uploaded to the DizzyDoctor website. For a fee, this data can be processed for the purpose of diagnosing.

Sensorion Announces Publication of Seliforant Phase 1 Study Data

by Karl | Sep 27, 2018 | Vestibular Training, Vestibular Treatment | 0

Seliforant (formerly SENS-111) is currently being studied in an ongoing Phase 2 trial for the treatment of acute unilateral vestibulopathy, a debilitating disease of the inner ear. Its maker, Sensorion, has announced the publication of data in the ‘British Journal of Clinical Pharmacology’ from a Phase 1 study evaluating the safety, tolerability, pharmacokinetics of the drug in healthy subjects. More data are expected at the end of 2018.

Swedish University Researchers Develop New Test for Balance Disorders

by Stefani Kim | Sep 13, 2018 | Vestibular Care, Vestibular Training, Vestibular Treatment | 0

Researchers from Chalmers University of Technology have developed a new device using bone conduction technology that is said to offer “significant advantages” over current tests.

Sensorion Receives Approval for SENS-401 Phase 2 Clinical Trial

by Stefani Kim | Aug 21, 2018 | Vestibular Training, Vestibular Treatment | 0

The randomized, double-blind, placebo-controlled Phase 2 study will be conducted across 50 sites in Europe, the US, Canada, Israel, and Turkey, and enroll approximately 260 patients.

Sensorion Announces Initiation of Phase 2 Study for Vertigo Drug Seliforant

by Stefani Kim | Jul 26, 2018 | Vestibular Care, Vestibular Training, Vestibular Treatment | 0

By comparing the effects of seliforant to meclizine, a drug with known anticholinergic side effects, and placebo, the SENS-111-202 study aims to confirm the absence of anticholinergic effects such as sedation and memory loss in patients receiving seliforant.

Soccer Headers May Be Linked to Increase in Balance Problems

by Stefani Kim | Jul 13, 2018 | Vestibular Care, Vestibular Testing, Vestibular Training, Vestibular Treatment | 0

The study found that the players with the largest number of headers had the largest balance responses to GVS in both foot placement and hip adduction during the walking test, which indicated that they had vestibular processing and balance recovery problems.

New Research Pinpoints Mechanism Behind Sound-Induced Vertigo

by Stefani Kim | Jul 12, 2018 | Rehab & Therapeutics, Vestibular Care, Vestibular Training | 0

It has been estimated that 1 in 100 people around the world have a congenital inner ear condition known as semicircular canal dehiscence, a thinning of the bone enclosing the inner ear that can lead to vertigo in response to certain sounds, changes in atmospheric pressure, or coughing.